Diadema Partners »

Cartesian Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $907k 87k 10.42

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Cartesian Therapeutics

Squarepoint Ops
BlackRock
683 Capital Management
Vanguard Capital Management
FMR
Geode Capital Management
AQR Capital Management
Millennium Management
Two Sigma Investments
Marshall Wace
UBS Group
Jupiter Topco
State Street Corporation
Privium Fund Management B.V.
Susquehanna International

View all funds holding Cartesian Therapeutics